Who owns FREELINE THERAPEUTICS HLDGS?
- Ticker: FRLN
- CUSIP Number: 35655l107
Tip: Access positions for across all investors
Analyze quarterly positions in Freeline Therapeutics Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Freeline Therapeutics Hldgs stock
Who bought or sold FREELINE THERAPEUTICS HLDGS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
|---|---|---|---|---|---|---|
| Syncona Portfolio | 22M | $19M | 0% | Jun 2022 | ||
| CHI Advisors | 4.9M | $4.2M | 0% | Jun 2022 | ||
| Polygon Management | 3.7M | $4.1M | 143% | Mar 2022 | ||
| Eventide Asset Management | 3.6M | $4.0M | 3% | Mar 2022 | ||
| UBS Group | 505k | $535k | 100% | Mar 2022 | ||
| Renaissance Technologies | 265k | $231k | -41% | Jun 2022 | ||
| Morgan Stanley | 185k | $207k | 100% | Mar 2022 | ||
| Harbor Capital Advisors | 147k | $129k | 1% | Jun 2022 | ||
| Two Sigma Investments | 133k | $149k | 223% | Mar 2022 | ||
| Federated Investors | 60k | $67k | 50% | Mar 2022 | ||
| Values First Advisors | 56k | $49k | 12% | Jun 2022 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Freeline Therapeutics Hldgs? |
||||||
| Veritable | 56k | $63k | 0% | Mar 2022 | ||
| SG Americas Securities | 52k | $45k | -13% | Jun 2022 | ||
| Acadian Asset Management | 27k | $30k | 100% | Mar 2022 | ||
| Two Sigma Advisers | 24k | $27k | 100% | Mar 2022 | ||
| Aspire Private Capital | 1.2k | $999.960000 | 100% | Mar 2022 | ||
Who sold out of Freeline Therapeutics Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Novo A/S | Dec 2021 | 1.8M | $3.5M |
| Wellington Management Company | Dec 2021 | 440k | $867k |
| Axa | Dec 2021 | 284k | $562k |
| Marshall Wace | Dec 2021 | 111k | $218k |
| Prospera Financial Services | Mar 2022 | 35k | $39k |
| Woodline Partners | Dec 2021 | 26k | $51k |
| Jpmorgan Chase & Co | Mar 2022 | 664.00 | $999.984000 |